Michael E. Meyers, MPH

New York, New York, United States
Michael E. Meyers, M.P.H., is Vice Chairman, Head of M&A and Strategic Advisory Services at H.C. Wainwright & Co. Mr. Meyers has over 25 years of investment banking, venture capital, asset management and operating experience in healthcare, with an emphasis on the life sciences.

Over the course of his career, Mr. Meyers has advised on over $130 billion of strategic and financial transactions.

Previously, Mr. Meyers was Head of Investment Banking at T.R. Winston & Company, a merchant bank; CEO and CIO of Arcoda Capital Management, a health care asset management company that he founded with Scott Gottlieb, M.D.; Partner and Portfolio Manager with GoldenTree Asset Management; a Managing Partner and Portfolio Manager at Trivium Capital Management; Managing Director, Partner and Member of the Board of Global Biomedical Partners AG, a life sciences venture capital firm that was acquired by HBM Bioventures; Director and Relationship Manager with Merrill Lynch & Co., with responsibility for biotechnology and pharmaceutical investment banking. Prior to joining Merrill Lynch, Mr. Meyers was a Vice President of Health Care Investment Banking with Cowen & Company, and a Research Associate in Biotechnology and Medical Devices with Hambrecht & Quist.

Mr. Meyers serves on the Board of Trustees of the Ronald Reagan UCLA Medical Center; the University of Southern California’s Board of Councilors - Stevens Center for Innovation and the School of Dramatic Arts.

Mr. Meyers holds an M.P.H. in Health Policy and Management from Columbia University, and an A.B. in Biology from Brandeis University.
Speaking In
12:00 PM - 1:00 PM (EST)
Tuesday, February 16
Rahul Singhvi is a global leader in the Life Sciences industry and serves as the Chief Executive…